Chambers Michael Andrew
SEC insider (Form 3/4/5 filer). CIK 0001932527. Director at Sarepta Therapeutics, Inc. (SRPT). 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 4, 2026. Located in CAMBRIDGE, MA.
Companies Chambers Michael Andrew has filed insider reports for
- Sarepta Therapeutics, Inc. (SRPT): Director
Chambers Michael Andrew
CIK: 0001932527
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (75.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (25.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SRPT
Sarepta Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 4, 2026SRPT
Sarepta Therapeutics, Inc.
AwardDirect16.9K shares- - Dec 18, 2025SRPT
Sarepta Therapeutics, Inc.
DispositionIndirectConvertible Senior Notes
0 shares- - Dec 18, 2025SRPT
Sarepta Therapeutics, Inc.
AwardIndirectConvertible Senior Notes
0 shares- - Mar 10, 2025SRPT
Sarepta Therapeutics, Inc.
AwardDirect2.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 4, 2026 | SRPT Sarepta Therapeutics, Inc. | Award | 16,875 | - | $0 | Direct |
| Dec 18, 2025 | SRPT Sarepta Therapeutics, Inc. | Disposition Convertible Senior Notes | 0 | - | - | Indirect |
| Dec 18, 2025 | SRPT Sarepta Therapeutics, Inc. | Award Convertible Senior Notes | 0 | - | - | Indirect |
| Mar 10, 2025 | SRPT Sarepta Therapeutics, Inc. | Award | 2,383 | - | - | Direct |
1-4 of 4 transactions